Company ProMetic Life Sciences Inc. Toronto S.E.
Equities
CA74342Q1046
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 14/08/14 | |
Director of Finance/CFO | 51 | 02/22/02 | |
Patrick Sartore
PSD | President | 49 | 01/06/01 |
Gary Bridger
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/19/01 |
Director/Board Member | 67 | 14/14/14 | |
Shrinal Inamdar
IRC | Investor Relations Contact | - | - |
Marie Iskra
LAW | General Counsel | 48 | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Bridger
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/19/01 |
Director/Board Member | 67 | 14/14/14 | |
Alek Krstajic
CHM | Chairman | 60 | 01/20/01 |
Neil Klompas
BRD | Director/Board Member | 52 | 01/19/01 |
Eugene Siklos
BRD | Director/Board Member | 60 | 01/20/01 |
Director/Board Member | 63 | 01/19/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,249,534 | 1,258,903 ( 38.74 %) | 0 | 38.74 % |
Company contact information
Liminal BioSciences, Inc.
440, boulevard Armand-Frappier Suite 300
H7V 4B4, Laval
+450 781 0115
http://www.liminalbiosciences.com![address ProMetic Life Sciences Inc.](https://cdn.zonebourse.com/static/address/1411267.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+18.97% | 4.53TCr | |
+42.66% | 4.04TCr | |
-10.06% | 3.79TCr | |
+31.15% | 3.18TCr | |
-7.79% | 2.77TCr | |
+13.32% | 2.65TCr | |
+43.05% | 1.4TCr | |
+31.28% | 1.24TCr | |
-7.41% | 1.13TCr |